AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Individualized Rehabilitation for Osgood-Schlatter or Sever Pain in Youth Athletes

RecruitingNAAges 10 Years - 17 YearsAllMedical University of Gdansk
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if a 12-week individualized rehabilitation program is feasible and helpful for children and adolescents with lower-extremity apophyseal pain, including Osgood-Schlatter-related knee pain and Sever-related heel pain. It will also learn about how well participants follow the program, whether the program can be delivered as planned, and whether pain, function, and sports participation improve during rehabilitation. The main questions it aims to answer are: 1. Can this rehabilitation program be delivered with good attendance, good home-exercise adherence, and complete follow-up data? 2. Do pain, function, and sports participation improve during the rehabilitation period? 3. Which baseline clinical, functional, ultrasound, maturity, or biomarker features may help explain who responds better to rehabilitation? All participants will receive the sam

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Aged 10 to 17 years * Participates in organized sport and has at least 12 months of sport participation or training history * Has current lower-extremity apophyseal pain consistent with Osgood-Schlatter-related knee pain, Sever-related heel pain, and/or Sinding-Larsen-Johansson-related pain at the inferior pole of the patella, or has previous symptoms of these conditions with a residual or low-irritability presentation relevant to rehabilitation * Meets criteria for at least one pre-specified rehabilitation entry pathway: post-trial rehabilitation entry after completion of the separate photobiomodulation trial, or direct-entry rehabilitation with active apophyseal symptoms, or direct-entry rehabilitation with previous Osgood-Schlatter-related or Sever-related symptoms and a low-irritability or residual presentation For participants entering with active symptoms: * pain is located at the tibial tubercle region, the inferior pole of the patella, and/or the calcaneal apophyseal/heel region * pain is aggravated by activity, loading, or sport participation * pain is reproducible on clinical examination or the clinical history is consistent with the target condition Participant and parent/caregiver are willing to take part in the rehabilitation program, including in-person visits, home exercises, symptom/activity monitoring, and follow-up assessments. A parent or legal guardian provides written informed consent, and the participant provides assent when applicable. Exclusion Criteria: * Current pain episode started after an acute traumatic injury that better explains the symptoms * Clinical presentation suggests a condition other than the target rehabilitation condition, including a major alternative knee or heel diagnosis requiring different management * Lower-limb surgery that would substantially affect rehabilitation planning, safety, or interpretation of outcomes * Known serious musculoskeletal, neurological, rheumatological, inflammatory, autoimmune, metabolic, or other systemic disease that may affect safe participation or interpretation of outcomes * Any medical or developmental condition that would prevent safe participation in exercise-based rehabilitation * Current symptoms requiring urgent medical assessment or management outside the rehabilitation pathway * Inability to understand study instructions or complete study procedures with parent/caregiver support * Parent/caregiver or participant does not agree to participate or withdraws consent/assent
๐Ÿ’Š

What it tests

  • Individualized Load-Based Rehabilitation Pathway
๐Ÿ“

Where

1 site
Department of Immunobiology and Environment Microbiology
Gdansk, Poland
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy